Abatacept is useful in autoimmune cytopenia with immunopathologic manifestations caused by CTLA-4 defects

被引：13
|
作者：
Dhunputh, C. [1 ,2 ]
Ducassou, S. [1 ,2 ]
Fernandes, H. [2 ]
Picard, Capucine [3 ,4 ]
Rieux-Laucat, Frederic
Viallard, J. -F. [5 ]
Lazaro, E. [5 ]
Hermine, O. [6 ]
Jouvray, M. [7 ]
Machelard, I. [8 ]
Lambilliotte, A. [9 ]
Malphettes, M. [10 ]
Moshous, D. [11 ]
Neven, B. [11 ]
Gauthier, A. [12 ,13 ]
Garnier, N.
Leblanc, T. [14 ]
Landman-Parker, J. [15 ]
Leverger, G. [15 ]
Aladjidi, N. [1 ,2 ]
机构：
[1] Bordeaux Univ Hosp, INSERM Plurithemat CIC CICP, Pediatr Hematoimmunol Ctr Invest Clin CIC, Bordeaux, France
[2] Bordeaux Univ Hosp, Ctr Reference Natl Cytopenies Autoimmunes Enfant, Bordeaux, France
[3] Univ Paris, APHP, Necker Hosp Sick Children, Study Ctr Primary Immunodeficiencies, Paris, France
[4] Inst Imagine, INSERM, Unite Mixte Rech UMR 1163, Lab Immunogenet Pediat Autoimmune Dis, Paris, France
[5] Bordeaux Univ Hosp, Dept Internal Med & Infect Dis, Bordeaux, France
[6] Necker Enfants Malades Univ Hosp, AP HP, Hematol Unit, Paris, France
[7] Hosp Arras, Dept Internal Med, Arras, France
[8] Hosp Bayonne, Dept Internal Med, Bayonne, France
[9] Lille Univ Hosp, Dept Pediat Hematol, Lille, France
[10] St Louis Univ Hosp, AP HP, Clin Immunol Dept, Paris, France
[11] Necker Enfants Malades Univ Hosp, AP HP, Pediatr Immunohematol & Rheumatol Dept, Paris, France
[12] Hosp Civils Lyon, Pediatr Hematol & Oncol Inst, Lyon, France
[13] Univ Lyon, Univ Claude Bernard Lyon 1, Team Vascular Biol & Red Blood Cell, Lab Interuniversitaire Biol Motricit,EA7424, Lyon, France
[14] Robert Debre Univ Hosp, AP HP, Pediatr Hematol & Immunol Dept, Paris, France
[15] Armand Trousseau Univ Hosp, AP HP, Pediatr Oncol Immunol Hematol Unit, Paris, France
来源：
BLOOD | 2022年 / 139卷 / 02期
关键词：
RHEUMATOID-ARTHRITIS; IMMUNE DYSREGULATION; SAFETY;
D O I：
10.1182/blood.2021013496
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：300 / 304
页数：5
相关论文
共 17 条
  • [1] Abatacept alleviates severe autoimmune symptoms in a patient carrying a de novo variant in CTLA-4
    Lee, Sangmoon
    Moon, Jin Soo
    Lee, Cho-Rong
    Kim, Hye-Eun
    Baek, Sun-Mi
    Hwang, Solha
    Kang, Gyeong Hoon
    Seo, Jeong Kee
    Shin, Choong Ho
    Kang, Hyoung Jin
    Ko, Jae Sung
    Park, Sung Gyoo
    Choi, Murim
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (01) : 327 - 330
  • [2] CTLA-4: From mechanism to autoimmune therapy
    Hosseini, Arezoo
    Gharibi, Tohid
    Marofi, Faroogh
    Babaloo, Zohreh
    Baradaran, Behzad
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 80
  • [3] Induction of autoimmune disease by deletion of CTLA-4 in mice in adulthood
    Klocke, Katrin
    Sakaguchi, Shimon
    Holmdahl, Rikard
    Wing, Kajsa
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (17) : E2383 - E2392
  • [4] CTLA-4 haploinsufficiency in a patient with an autoimmune lymphoproliferative disorder
    Kucuk, Zeynep Yesim
    Charbonnier, Louis-Marie
    McMasters, Richard L.
    Chatila, Talal
    Bleesing, Jack J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 140 (03) : 862 - +
  • [5] Current understanding of CTLA-4: from mechanism to autoimmune diseases
    Hossen, Md Munnaf
    Ma, Yanmei
    Yin, Zhihua
    Xia, Yuhao
    Du, Jing
    Huang, Jim Yi
    Huang, Jennifer Jin
    Zou, Linghua
    Ye, Zhizhong
    Huang, Zhong
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [6] Pulmonary manifestations of immune dysregulation in CTLA-4 haploinsufficiency and LRBA deficiency
    Krone, Katie A.
    Winant, Abbey J.
    Vargas, Sara O.
    Platt, Craig D.
    Bartnikas, Lisa M.
    Janssen, Erin
    Lillehei, Craig
    Lee, Edward Y.
    Fishman, Martha P.
    Casey, Alicia
    PEDIATRIC PULMONOLOGY, 2021, 56 (07) : 2232 - 2241
  • [7] A Patient with CTLA-4 Haploinsufficiency with Multiple Autoimmune Presentations: A Case Report
    Zaremehrjardi, Fatemeh
    Baniadam, Leila
    Seif, Farhad
    Arshi, Saba
    Bemanian, Mohammad Hassan
    Shokri, Sima
    Rezaeifar, Afshin
    Fallahpour, Morteza
    Nabavi, Mohammad
    IRANIAN JOURNAL OF IMMUNOLOGY, 2020, 17 (03) : 244 - 249
  • [8] Study of an extended family with CTLA-4 deficiency suggests a CD28/CTLA-4 independent mechanism responsible for differences in disease manifestations and severity
    Hou, Tie Zheng
    Olbrich, Peter
    Lucena Soto, Jose Manuel
    Sanchez, Berta
    Sanchez Moreno, Paula
    Borte, Stephan
    Stauss, Hans J.
    Burns, Siobhan O.
    Walker, Lucy S. K.
    Pan-Hammarstrom, Qiang
    Hammarstrom, Lennart
    Sansom, David M.
    Neth, Olaf
    CLINICAL IMMUNOLOGY, 2018, 188 : 94 - 102
  • [9] Comparing the levels of CTLA-4-dependent biological defects in patients with LRBA deficiency and CTLA-4 insufficiency
    Catak, Mehmet C.
    Akcam, Bengu
    Eltan, Sevgi Bilgic
    Babayeva, Royala
    Karakus, Ibrahim S.
    Akgun, Gamze
    Baser, Dilek
    Bulutoglu, Alper
    Bayram, Feyza
    Kasap, Nurhan
    Kiykim, Ayca
    Hancioglu, Gonca
    Karadag, Sefika I. Kokcu
    Demirkol, Yasemin Kendir
    Ozen, Selime
    Cekic, Sukru
    Ozcan, Dilek
    Karaca, Neslihan Edeer
    Sasihuseyinoglu, Ayse S.
    Cansever, Murat
    Yucel, Esra Ozek
    Tamay, Zeynep
    Altintas, Derya U.
    Aydogmus, Cigdem
    Celmeli, Fatih
    Cokugras, Haluk
    Gulez, Nesrin
    Genel, Ferah
    Metin, Ayse
    Guner, Sukru N.
    Kutukculer, Necil
    Keles, Sevgi
    Reisli, Ismail
    Kilic, Sara S.
    Yildiran, Alisan
    Karakoc-Aydiner, Elif
    Lo, Bernice
    Ozen, Ahmet
    Baris, Safa
    ALLERGY, 2022, 77 (10) : 3108 - 3123
  • [10] Overexpression and Secretion of the Soluble CTLA-4 Splice Variant in Various Autoimmune Diseases and in Cases with Overlapping Autoimmunity
    AlFadhli, Suad
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2013, 17 (04) : 336 - 341
12